Navigation Links
Tennessee Breast Center Selects Sectra RIS/PACS
Date:10/1/2013

SHELTON, Connecticut, October 1, 2013 /PRNewswire/ --

Knoxville Comprehensive Breast Center (KCBC), a full-service breast health care practice, has recently signed an agreement with the international medical imaging IT company,Sectra  (STO: SECT B).  Under the agreement, KCBC will utilize Sectra breast imaging PACS and RIS to provide improved service to its referring physician community and patient population.

     (Logo: http://photos.prnewswire.com/prnh/20120601/537255)

With Sectra's solution, KCBC will offer its referring physicians the ability to order studies on-line to ensure prompt scheduling for their patients.  The KCBC staff will gain efficiencies via a unified system from image acquisition through report distribution.  

"Sectra was a logical choice for our practice," says the KCBC Administrator, Michelle Oglesby. "We wanted a system that provided full PACS viewing functionality for breast MRI and ultrasound, as well as mammography.  The logical hanging protocols and excellent toolset will allow us to continue to be the leader in breast health care in the Knoxville community."

Sectra Breast Imaging PACS is a web-based, multi-modality workstation featuring advanced diagnostic tools, including integrated CAD and reporting, that offers a single-system reading environment for mammographers.  All digital breast images, regardless of modality vendor, are automatically displayed in the same size with correct orientation and alignment, facilitating comparison of current and prior images.  

About Sectra

With more than 20 years in the business, Sectra develops and sells IT systems and services for radiology, women's health, orthopaedics and rheumatology. More than 1,400 hospitals, clinics and imaging centers worldwide use the systems daily, together performing over 70 million radiology examinations annually. This makes Sectra one of the world-leading companies within systems for handling digital radiology images. Sectra's systems have been installed in North America, Scandinavia and most major countries in Europe and the Far East. For more information, visit http://www.sectra.com

About Knoxville Comprehensive Breast Center

The Knoxville Comprehensive Breast Center comprises a staff of over 70 employees including 5 physicians specializing in breast care and utilizing digital mammographic machines, 10 ultrasound machines, a stereotactic table, 2 dedicated Breast MRI machines and a Digital Mobile Mammography Coach.  Founder and Medical Director, Dr. Kamilia Kozlowski has delivered exceptional breast care to women in the area since 1983. For more information, visit http://www.knoxvillebreastcenter.com

Contact:
Andrea Sowitch
Director of Marketing
Sectra North America
E-mail: Andrea.Sowitch@sectra.com
Phone: +1-203-925-0899 ext 268
http://www.sectra.com/medical    


'/>"/>
SOURCE Sectra North America Inc
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Bayer CropScience Breaks Ground on New Greenhouse For Cotton Research And Development in Memphis, Tennessee
2. Maryville, Tennessee Based Molecular Pathology Laboratory Network (MPLN) Celebrates 38th Annual Medical Laboratory Professional Week by Honoring Employees
3. Avon Foundation for Women, NIH, and the Center for Advancing Innovation Launch Start-Up Challenge to Advance Breast Cancer Biomedical Invention
4. MarketResearchReports.Biz: Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma And Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019 - New Industry Report
5. FreeMyGenes.org and Facebook Campaign Launched to Raise Awareness of Fight to Make Genetic Testing for Breast and Other Cancers More Affordable and Accessible
6. Montclair Breast Center Introduces Online Breast Cancer Risk Quiz
7. Signal Genetics Announces Publication of BreastPRS™ Validation Study with Weill Cornell Medical College, New York
8. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
9. CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
10. Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers at ASCO and EHA
11. MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... -- This report analyzes the worldwide markets for Biofuel Enzymes ... Cellulase, and Others. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... of World. Read the full report: ... for the period 2015 through 2022. Also, a six-year historic ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... with catheters associated with peritoneal dialysis, announced today that it has published the ... connection system in Peritoneal Dialysis International (PDI), the official Journal of the ...
(Date:2/18/2017)... Kurzlehrgang mit Fokus auf Assay zum ... metaproteomische Analyse des Darm-Mikrobioms bei Säuglingen dar   ... Wie ... Peretz , Scientific Director bei ImmuneCarta, einen Kurzlehrgang zu ... intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien im Rahmen der jährlich ...
(Date:2/17/2017)... , Feb. 17, 2017  BioGenex, a global ... development of a novel system for quantitative immunohistochemistry ... the University of Rochester (NY, USA) and Konica-Minolta ... new system is able to accurately quantify the ... (Human epidermal growth factor receptor-2) in clinical samples. ...
Breaking Biology Technology:
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion in ... a compound annual growth rate (CAGR) of 24.0% through 2021. ... for synthetic biology. - Analyses of global market trends, with ... annual growth rates (CAGRs) through 2021. - Coverage of core ...
(Date:2/7/2017)... WARSAW, Ind. , Feb. 7, 2017 ... global leader in musculoskeletal healthcare, will present at the ... Lotte New York Palace Hotel on Wednesday, February 15, ... A live webcast of the presentation can be accessed ... for replay following the conference via Zimmer Biomet,s Investor ...
Breaking Biology News(10 mins):